Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

AGRX | Agile Therapeutics, Inc.

Index- P/E0.31 EPS (ttm)5.93 Insider Own0.20% Shs Outstand1.93M Perf Week-11.65%
Market Cap3.40M Forward P/E- EPS next Y-11.00 Insider Trans0.00% Shs Float1.81M Perf Month-14.55%
Income3.10M PEG- EPS next Q-6.00 Inst Own5.70% Short Float / Ratio0.59% / 0.21 Perf Quarter-40.33%
Sales16.30M P/S0.21 EPS this Y96.00% Inst Trans- Short Interest0.01M Perf Half Y-84.92%
Book/sh-6.85 P/B- EPS next Y- ROA21.10% Target Price- Perf Year-90.11%
Cash/sh1.50 P/C1.22 EPS next 5Y- ROE-59.70% 52W Range1.86 - 18.61 Perf YTD-83.96%
Dividend- P/FCF- EPS past 5Y49.70% ROI1167.80% 52W High-90.22% Beta1.16
Dividend %- Quick Ratio0.60 Sales past 5Y- Gross Margin54.70% 52W Low-2.15% ATR0.18
Employees22 Current Ratio0.80 Sales Q/Q161.90% Oper. Margin- RSI (14)33.20 Volatility6.06% 7.49%
OptionableNo Debt/Eq- EPS Q/Q96.20% Profit Margin19.10% Rel Volume0.33 Prev Close1.88
ShortableYes LT Debt/Eq- EarningsAug 09 BMO Payout0.00% Avg Volume51.07K Price1.82
Recom3.00 SMA20-16.59% SMA50-26.37% SMA200-75.22% Volume17,082 Change-3.19%
Date Action Analyst Rating Change Price Target Change
Apr-07-21Resumed RBC Capital Mkts Outperform $8
Apr-12-19Resumed Janney Buy $4
Nov-29-18Initiated Maxim Group Buy $3
Dec-26-17Downgrade William Blair Outperform → Mkt Perform
Dec-26-17Downgrade Janney Buy → Neutral
Oct-02-17Resumed H.C. Wainwright Buy $10
Sep-14-17Reiterated RBC Capital Mkts Outperform $8 → $10
Jul-19-17Initiated H.C. Wainwright Buy $10
Jan-08-16Initiated Cantor Fitzgerald Buy
Apr-02-15Initiated FBR Capital Outperform $17
Jun-17-14Initiated RBC Capital Mkts Outperform $12
Sep-05-23 08:05AM
Aug-17-23 09:00AM
Aug-11-23 09:35AM
Aug-09-23 08:14AM
08:30AM Loading…
Jul-26-23 08:30AM
Jul-19-23 09:00AM
Jul-18-23 09:00AM
Jul-11-23 09:15AM
Jul-05-23 09:00AM
Jul-03-23 09:00AM
Jun-30-23 09:00AM
Jun-28-23 09:00AM
Jun-27-23 03:36PM
Jun-26-23 08:01AM
12:05PM Loading…
Jun-23-23 12:05PM
Jun-15-23 04:05PM
Jun-14-23 11:29AM
Jun-13-23 04:05PM
May-25-23 04:05PM
May-22-23 08:00PM
May-12-23 06:29AM
May-11-23 04:43PM
May-08-23 08:00AM
Apr-28-23 08:01AM
Apr-26-23 09:01AM
Apr-10-23 04:30PM
Apr-05-23 05:30AM
Mar-27-23 02:25AM
12:49PM Loading…
Mar-23-23 12:49PM
Mar-22-23 04:05PM
Mar-21-23 09:05AM
Feb-27-23 08:31AM
Feb-20-23 09:40AM
Feb-15-23 08:00AM
Feb-09-23 08:00AM
Feb-03-23 09:40AM
Feb-01-23 08:01AM
Jan-26-23 04:30PM
Jan-20-23 08:45AM
Jan-18-23 09:40AM
Jan-09-23 07:00AM
Dec-21-22 09:05AM
Dec-01-22 08:30AM
Nov-15-22 08:15AM
Nov-07-22 04:05PM
Oct-26-22 08:30AM
Oct-21-22 11:00AM
Oct-07-22 04:25PM
Sep-06-22 08:30AM
Aug-11-22 09:30PM
Jul-28-22 08:05AM
Jul-26-22 03:47PM
Jul-14-22 08:45AM
Jul-12-22 02:33PM
Jul-08-22 08:05AM
Jul-06-22 05:16PM
Jul-01-22 09:20AM
Jun-28-22 09:58AM
May-17-22 08:01AM
May-13-22 12:00AM
May-12-22 04:05PM
May-05-22 05:01PM
May-03-22 07:30AM
Apr-26-22 10:46AM
Apr-19-22 09:53AM
Apr-14-22 07:30AM
Apr-11-22 07:05AM
Apr-07-22 07:30AM
Mar-31-22 07:30AM
Mar-30-22 11:00PM
Mar-23-22 05:45PM
Mar-14-22 06:07PM
Mar-11-22 08:01AM
Mar-10-22 05:55PM
Mar-07-22 08:01AM
Feb-24-22 06:00PM
Feb-15-22 10:14AM
Jan-31-22 05:38PM
Jan-21-22 01:38PM
Jan-12-22 05:29PM
Jan-10-22 08:01AM
Jan-05-22 08:03AM
Nov-30-21 10:54AM
Nov-02-21 06:45PM
Oct-22-21 08:01AM
Oct-19-21 05:04AM
Oct-18-21 07:02AM
Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. The company was incorporated in 1997 and is headquartered in Princeton, New Jersey.